| abstract |
The present invention relates to intraluminal methods and compositions for treating subjects with breast disorders. The composition is a repolarizing agent capable of repolarizing M2 macrophages to M1 macrophages, reducing M2 macrophages, increasing M1 macrophages and/or increasing the sensitivity of a subject to chemotherapy in the tumor microenvironment, and Includes polarization blockers. |